发明授权
- 专利标题： Ophthalmic compositions for treating ocular hypertension
- 专利标题（中）： 用于治疗高眼压症的眼用组合物
-
申请号： US10570231申请日： 2004-08-31
-
公开(公告)号： US07494983B2公开(公告)日： 2009-02-24
- 发明人: Meng Hsin Chen , James B. Doherty , Luping Liu , Swaminathan Natarajan , Robert M. Tynebor
- 申请人： Meng Hsin Chen , James B. Doherty , Luping Liu , Swaminathan Natarajan , Robert M. Tynebor
- 申请人地址： US NJ Rahway
- 专利权人： Merck & Co. Inc.
- 当前专利权人： Merck & Co. Inc.
- 当前专利权人地址： US NJ Rahway
- 代理商 Sylvia A. Ayler; William Krovatin
- 国际申请： PCT/US2004/028351 WO 20040831
- 国际公布： WO2005/255568 WO 20050324
- 主分类号： A61K31/675
- IPC分类号： A61K31/675 ; A61K31/4439 ; C07F9/06
摘要：
This invention relates to potent potassium channel blocker compounds of structural Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.
公开/授权文献
- US20070027188A1 Ophthalmic compositions for treating ocular hypertension 公开/授权日：2007-02-01
信息查询
